Healthcare News and Research

Latest Healthcare News and Research

L.A. Times: More than 9 million uninsured gain coverage

The newspaper's tally draws on state and federal enrollment reports, surveys by consultants and interviews with insurance and government officials. Meanwhile, insurers and others intensify efforts to sign up young customers.

1 Apr 2014

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Binghamton University was recently awarded a HEARTSafe Campus accreditation from the National Collegiate Emergency Medical Services Foundation, making Binghamton one of only five colleges and universities in the United States and Canada to achieve the accreditation.

1 Apr 2014

22 new Centres for Doctoral Training

Postgraduate training in a wide range of engineering and scientific fields important to the UK's economy received a further boost today. Twenty two new Centres for Doctoral Training (CDTs) were announced by the Chancellor of the Exchequer, The Rt. Hon George Osborne MP.

1 Apr 2014

Americans' experience with health law depends on where they live

Some states that embraced the law, like Oregon, have had difficulty enrolling residents because of glitch-ridden online marketplaces, while others like New Hampshire have seen unexpectedly strong enrollments despite prevailing critical views.

31 Mar 2014

Artists benefit from health law, but rural residents may pay more

Self-employed Americans such as artists stand to gain under the health law, but rural residents may pay more for coverage because of the higher costs of delivering care in a sparsely populated area and the disproportionate number of older people. Other media outlets offer advice for consumers trying to make sense of the law.

31 Mar 2014

Cellulose nanofiber paper filter removes virus particles with high efficiency

Researchers at the Division of Nanotechnology and Functional Materials, Uppsala University have developed a paper filter, which can remove virus particles with the efficiency matching that of the best industrial virus filters. The paper filter consists of 100 percent high purity cellulose nanofibers, directly derived from nature.

31 Mar 2014

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

Concert Pharmaceuticals, Inc. today reported financial results for the year ended December 31, 2013 and provided an update on corporate activities.

31 Mar 2014

BCBSA honors Empire BlueCross BlueShield with Brand Excellence Award

Empire BlueCross BlueShield announced today that it has received a Brand Excellence Award from the Blue Cross and Blue Shield Association. The annual awards honor Blue Cross and Blue Shield companies that excel in developing and enhancing the overall Blue Cross and Blue Shield Brand image.

31 Mar 2014

First Edition: March 31, 2014

Today's early morning highlights from the major news organizations offer assessments of the administration's campaign to get people signed up for health care and a look at the issues going forward after today's deadline for most enrollments.

31 Mar 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.

31 Mar 2014

Genetic markers could help predict heart attack in patients with heart disease

Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future.

31 Mar 2014

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Otsuka Pharmaceutical Co., Ltd. has announced an agreement with Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd. to acquire rights to the hematological cancer treatment Dacogen and to an enzyme inhibitor, E7727.

31 Mar 2014

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Forest Laboratories, Inc. and Gedeon Richter Plc. today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigational antipsychotic cariprazine in patients with bipolar depression.

31 Mar 2014

Dongkook Pharmaceutical to launch Probi Mage dietary supplement in South Korea

Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd., based in Seoul, South Korea for the distribution of Probi´s gut health product, Probi Mage®. The Product will be launched under Probi's brand in South Korea in the second quarter of 2014.

31 Mar 2014

Panasonic and KKR complete share purchase agreement

Panasonic Corporation ("Panasonic") and KKR, a leading global investment firm, today announced the completion of a share purchase agreement and a shareholders' agreement under which Panasonic and KKR have become joint partners of Panasonic Healthcare Co., Ltd. ("Panasonic Healthcare").

From PHC Europe B.V. 31 Mar 2014

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Today the U.S. Food and Drug Administration (FDA) approved over-the-counter Nexium® 24HR (esomeprazole 20mg) marking a key step towards providing those who suffer from frequent heartburn broader access to a brand doctors and patients have trusted for years.

31 Mar 2014

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

EKOS Corporation, a BTG International group company, notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC in the United States.

31 Mar 2014

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy (MADIT-CRT) study demonstrated significant and sustained survival benefit for the indicated population.

31 Mar 2014

Consumer Healthcare Products Association thanks Washington State gov for signing SSHB 2163 bill

The Consumer Healthcare Products Association thanks Washington State Governor Jay Inslee for signing SSHB 2163 and Rep. Paul Harris for the initial introduction of the legislation.

31 Mar 2014

Toshiba launches sleek, lightweight ultrasound system, Xario 200

Hospitals and imaging centers of any size can now access premium image quality with Toshiba America Medical Systems, Inc.'s Xario™ 200. The all-new ultrasound system is sleek and lightweight and takes the worry out of providing high-quality patient care with a compact ultrasound system.

31 Mar 2014

Healthcare News and Research

Latest Healthcare News and Research

L.A. Times: More than 9 million uninsured gain coverage

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

22 new Centres for Doctoral Training

Americans' experience with health law depends on where they live

Artists benefit from health law, but rural residents may pay more

Cellulose nanofiber paper filter removes virus particles with high efficiency

Concert Pharmaceuticals announces 2013 year-end results; posts record revenue of $25.4M

BCBSA honors Empire BlueCross BlueShield with Brand Excellence Award

First Edition: March 31, 2014

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Genetic markers could help predict heart attack in patients with heart disease

Otsuka inks agreement with Eisai to acquire rights to hematological cancer treatment Dacogen

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Dongkook Pharmaceutical to launch Probi Mage dietary supplement in South Korea

Panasonic and KKR complete share purchase agreement

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

MADIT-CRT study: Boston Scientific CRT defibrillator reduces risk of death in mild heart failure patients

Consumer Healthcare Products Association thanks Washington State gov for signing SSHB 2163 bill

Toshiba launches sleek, lightweight ultrasound system, Xario 200

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in